MoneyWorks4Me

Mercury Laboratories - Quaterly Results

24 Jul 2024 Evaluate
The sales declined to Rs. 166.77 millions for the June 2024 quarter as compared to Rs. 183.22 millions during the corresponding quarter last year.Profit after Tax for the quarter ended June 2024 saw a decline of -65.80% from Rs. 10.00 millions to Rs. 3.42  millions.Operating Profit reported a sharp decline to 17.56 millions from 18.06 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 166.77 183.22 -8.98 166.77 183.22 -8.98 755.59 753.34 0.30
Other Income 1.50 1.45 3.45 1.50 1.45 3.45 10.88 17.19 -36.71
PBIDT 17.56 18.06 -2.77 17.56 18.06 -2.77 101.20 102.90 -1.65
Interest 1.38 0.75 84.00 1.38 0.75 84.00 3.83 3.62 5.80
PBDT 16.18 17.31 -6.53 16.18 17.31 -6.53 97.37 99.28 -1.92
Depreciation 6.98 6.75 3.41 6.98 6.75 3.41 28.16 24.83 13.41
PBT 9.20 10.56 -12.88 9.20 10.56 -12.88 69.21 74.45 -7.04
TAX 5.78 0.56 932.14 5.78 0.56 932.14 12.66 18.66 -32.15
Deferred Tax 1.78 -2.94 -160.54 1.78 -2.94 -160.54 -6.34 -3.38 87.57
PAT 3.42 10.00 -65.80 3.42 10.00 -65.80 56.55 55.79 1.36
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 10.53 9.86 6.82 10.53 9.86 6.82 13.39 13.66 -1.95
Peers
Company Name CMP
Sun Pharma. Inds. 1841.50
Dr. Reddys Labs. 1243.65
Cipla 1386.75
Lupin 2083.15
Zydus Lifesciences 1213.55
View more..